Scroll To Top
Search by Speciality

4th ISIRV Antiviral Group Conference

University of Texas | Austin, USA
From 415 to 562 GBP
Event Preview
EXPIRED
This event
is Finished
Title: 4th ISIRV Antiviral Group Conference
Specialty: Immunology, Internal Medicine, Pulmonology
Dates: From Jun, 2, 2015 to Jun, 4, 2015
Location: Austin, USA
Type: Conference
Registration Cost: From 415 to 562 GBP
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Jun
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Austin, Usa.
General Info
Event Venue:

University of Texas

Austin, USA Visit the Venue to read more
Currency:
GBP
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Except for influenza, no antiviral therapies are currently approved for common or novel respiratory viral infections.


Resistance to the licensed anti-M2 and anti-NA antivirals poses a serious limitation to the options for therapeutic interventions against influenza.

There is therefore urgent need for novel therapies directed against other influenza virus targets or which modulate host factors and the immune response, to mitigate the pathogenic consequences of infection.

Similarly, effective therapeutics are needed for other seasonal respiratory viruses, like RSV and rhinoviruses, and for emergent viruses like MERS-CoV and EV-D68.

This theme is reflected in the WHO’s “Battle Against Respiratory Viruses” (BRAVE) initiative and in a RFA-A1-14-026 from NIAID “Development of novel therapeutics for select agents”.

The meeting will focus on the pre-clinical and clinical development of novel antivirals and therapeutics against influenza and other respiratory viruses, from discovery to licensure. The objective is to bring together those working in these areas to review current activity and progress.

The programme will include sessions on:

Novel influenza targets: polymerase, nucleoprotein and NS1 inhibitors


 New inhibitors of influenza NA and M2


 Inhibitors of HA function: DAS-181; fusion inhibitors; broad spectrum MAbs and smaller molecules targeting the HA stem


 Antivirals and antibody-based therapies against other seasonal and emerging respiratory viruses


 Host cell targets and determinants of host susceptibility: factors involved in virus replication or mediating the inflammatory response


 Combination therapies


 Clinical endpoints and regulatory issues

Registration Needs updating Register Now
Currency:

GBP

Registration Cost
Type
Early Registration

2015-03-31
Late Registration From: 2015-04-01 To: 0--
On site Registration
Early non member
511
632
0
Early member
415
536
0

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation
Accommodation:

AT&T Hotel & Conference Center at the University of Texas                                                       


1900 University Avenue,

Austin, TX 78705  

Reservations: Tel: + 512 404 3600

Scientific Content Up to Date
Submission Info

The organisers invite abstracts for oral or poster presentations in the following areas~


•New Inhibitors of Influenza Neuraminidase and M2 Protein Activities

•Inhibitors of Viral Polymerases, Nucleoproteins, or Accessory Proteins

•Inhibitors of Virion Attachment/Fusion Proteins

•Inhibitors of Other Respiratory Viruses - Both Seasonal and Emerging

•Host Cell Targets: Factors Involved in Virus Replication or Mediating the Inflammatory Response

•Antiviral Resistance

•Diagnostics Approaches

•Human Challenge Models

•Regulatory Issues and Endpoint Selection

Sponsors Exhibitors
General Info
ISIRV IS REGISTERED IN THE UNITED KINGDOM BOTH AS A CHARITY (NO.1118829) AND AS A COMPANY LIMITED BY GUARANTEE, THE FORMAT IN UK COMPANY LAW FOR NOT-FOR-PROFIT ORGANISATIONS, (NO. 06021083)
Contact
Organising Agency
ISIRV IS REGISTERED IN THE UNITED KINGDOM BOTH AS A CHARITY (NO.1118829) AND AS A COMPANY LIMITED BY GUARANTEE, THE FORMAT IN UK COMPANY LAW FOR NOT-FOR-PROFIT ORGANISATIONS, (NO. 06021083)
Event map
Revelant Events